A porous film that can freely design the "release amount" and "release time" of the drug.
[Sample available] Improves the "unevenness" of drug release with "zero-order release." Controls the release of volatile drugs by supporting them on a unique porous film. Applicable in various fields.
"Reisis" is a new technology that enables the controlled release of drugs by carrying them on a unique porous film. With Reisis, it becomes possible to maintain a constant effect (concentration) of volatile drugs through "zero-order release." Additionally, liquid raw materials can also be shaped and monomerized. It resolves the "dissatisfaction with drug effectiveness" and contributes to "effective," "long-lasting," and "stable" performance, while also reducing costs by eliminating waste. 【Features】 ■ Drugs accumulated in the porous gaps are constantly released in a consistent amount. ■ Almost all liquid drugs can be absorbed. ■ Does not require high-temperature heating during manufacturing. Please check below for examples of applications in various fields. *For more details, please refer to the PDF materials or feel free to contact us.
Inquire About This Product
basic information
【Other Features】 ■ The indicator function allows for the visualization of effects. *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
【Usage Examples】 1: Insect repellent pyrethroid type 2: Unpleasant pest control pyrethroid type 3: Sewage treatment pest control pyrethroid type 4: Vending machine pest control pyrethroid type 5: Cockroach control contact-type new formulation 6: Pest control in warehouses and factories growth hormone inhibitors, pheromone communication disruptors 7: Wild boar and deer control animal repellent 8: Fly and horsefly control pyrethroid type 9: Fragrance components natural types such as cedar and peppermint, various other synthetic types 10: Antibacterial and antifungal agents 11: Deodorants 12: Rust inhibitors 13: Drying agents 14: Oxygen absorbers 15: Cosmetic ingredient vitamin type 16: Transdermal absorption agents *For more details, please refer to the PDF document or feel free to contact us.
Detailed information
-
Zero emission
-
Indicator function
catalog（1）
Download All Catalogs
Company information
At Hagiwara Industrial Co., Ltd., in the Synthetic Resin Division, the Reisis Project Preparation Section is developing a new technology called "Reisis" that controls the release of drugs by carrying them on a unique porous film. This patent-pending technology can achieve zero-order release of drug concentration, allowing for constant control of the evaporation amount. Additionally, liquid raw materials can also be shaped and transformed into solid forms. By collaborating your drugs, products, and technologies with our technology, let's create new products and generate new value together.
![[Contracted ODM Services] Designated Quasi-Drug Example: Enafit](https://image.mono.ipros.com/public/product/image/0a4/2000390380/IPROS80455514614380724620.jpeg?w=280&h=280)
